Inhibition of Phosphodiesterase 5 and Increasing the Level of Cyclic Guanosine 3',5' Monophosphate by Hydroalcoholic C. Koch Extract in Human Breast Cancer Cell Lines MCF-7 and MDA-Mb-468

Overview

Journal Breast Cancer (Auckl)

Publisher Sage Publications

Date 2017 May 5

PMID 28469435

Citations 3

Authors

Ramin Saravani

Hamid Reza Galavi

Ali Shahraki

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the effect of hydroalcoholic C. Koch extract (HAWE) on phosphodiesterase 5 (PDE5) gene expression and cyclic guanosine 3',5' monophosphate (cGMP) signaling in the MCF-7 and MDA-Mb-468 cell lines. The effective dose (ED50) of HAWE was examined in both cell lines using a 3-(4,5-dimethylhiazol-2-yl)-2,5-diphenyltetrazolium bromide viability test, and the type of cell death was detected by flow cytometry. The expression of PDE5 and the concentration of cGMP were measured in a time-dependent manner in the ED50 by real-time polymerase chain reaction and a colorimetric assay, respectively. Treatment with HAWE showed 25 µg/mL to be the ED50 for both cell lines, and HAWE led to a reduction in the PDE5 messenger RNA expression. The intracellular cGMP increased in a time-dependent manner. The results showed that HAWE has an antiproliferative property in MCF-7 and MDA-Mb-468 cell lines through the cGMP pathway. Therefore, HAWE is a potential source to effectively isolate inhibitory PDE5.

Citing Articles

Enhanced hemocompatibility, antimicrobial and anti-inflammatory properties of biomolecules stabilized AgNPs with cytotoxic effects on cancer cells.

Chahardoli A, Qalekhani F, Hajmomeni P, Shokoohinia Y, Fattahi A Sci Rep. 2025; 15(1):1186.

PMID: 39775119 PMC: 11707122. DOI: 10.1038/s41598-024-82349-z.

Hydro-alcoholic Extract of C. Koch Reduces the Expression of Cell Death-Associated Genes while Inducing DNA Damage in HeLa Cervical Cancer Cells.

Sargazi S, Moudi M, Kooshkaki O, Mirinejad S, Saravani R Iran J Med Sci. 2020; 45(5):359-367.

PMID: 33060879 PMC: 7519407. DOI: 10.30476/ijms.2020.72657.0.

Hydroalcoholic Extract Induces Apoptosis and Alters and Gene Expression in Hela Cervical Cancer Cells.

Rezai M, Saravani R, Sargazi S, Moudi M, Shahroudi M, Saravani R Rep Biochem Mol Biol. 2020; 8(3):318-325.

PMID: 32274404 PMC: 7103081.

Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling.

Singh M, Kasna S, Roy S, Aldosary S, Saeedan A, Ansari M BMC Cancer. 2019; 19(1):996.

PMID: 31651285 PMC: 6814136. DOI: 10.1186/s12885-019-6152-9.

References

Roberts J, Booth L, Conley A, Cruickshanks N, Malkin M, Kukreja R . PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells. Cancer Biol Ther. 2014; 15(6):758-67. PMC: 4049791. DOI: 10.4161/cbt.28553. View

Catalano S, Campana A, Giordano C, Gyorffy B, Tarallo R, Rinaldi A . Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy. Clin Cancer Res. 2015; 22(9):2271-82. DOI: 10.1158/1078-0432.CCR-15-1900. View

Schmidt H, Hofmann F, Stasch J . Handbook of Experimental Pharmacology 191. cGMP: generators, effectors and therapeutic implications. Preface. Handb Exp Pharmacol. 2009; (191):v-vi. View

Savai R, Pullamsetti S, Banat G, Weissmann N, Ghofrani H, Grimminger F . Targeting cancer with phosphodiesterase inhibitors. Expert Opin Investig Drugs. 2009; 19(1):117-31. DOI: 10.1517/13543780903485642. View

Ballard S, Gingell C, Tang K, Turner L, Price M, Naylor A . Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol. 1998; 159(6):2164-71. DOI: 10.1016/S0022-5347(01)63299-3. View

Temkitthawon P, Viyoch J, Limpeanchob N, Pongamornkul W, Sirikul C, Kumpila A . Screening for phosphodiesterase inhibitory activity of Thai medicinal plants. J Ethnopharmacol. 2008; 119(2):214-7. DOI: 10.1016/j.jep.2008.05.034. View

Guillemin M, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V . In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med. 2002; 196(10):1373-80. PMC: 2193985. DOI: 10.1084/jem.20021129. View

Corbin J . Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res. 2004; 16 Suppl 1:S4-7. DOI: 10.1038/sj.ijir.3901205. View

Rahimi R, Ghiasi S, Azimi H, Fakhari S, Abdollahi M . A review of the herbal phosphodiesterase inhibitors; future perspective of new drugs. Cytokine. 2009; 49(2):123-9. DOI: 10.1016/j.cyto.2009.11.005. View

10.

Gao Y, Danciger M, Zhao D, Blaney J, Piriev N, Shih J . Screening of the PDE6B gene in patients with autosomal dominant retinitis pigmentosa. Exp Eye Res. 1996; 62(2):149-54. DOI: 10.1006/exer.1996.0019. View

11.

Karami-Tehrani F, Moeinifard M, Aghaei M, Atri M . Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors. Arch Med Res. 2012; 43(6):470-5. DOI: 10.1016/j.arcmed.2012.08.006. View

12.

Saravani R, Karami-Tehrani F, Hashemi M, Aghaei M, Edalat R . Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468. Cell Prolif. 2012; 45(3):199-206. PMC: 6496613. DOI: 10.1111/j.1365-2184.2012.00819.x. View

13.

Ning H, Xin Z, Lin G, Banie L, Lue T, Lin C . Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006; 68(6):1350-4. DOI: 10.1016/j.urology.2006.09.031. View

14.

Lin C . Tissue expression, distribution, and regulation of PDE5. Int J Impot Res. 2004; 16 Suppl 1:S8-S10. DOI: 10.1038/sj.ijir.3901207. View

15.

Reneerkens O, Rutten K, Steinbusch H, Blokland A, Prickaerts J . Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl). 2008; 202(1-3):419-43. PMC: 2704616. DOI: 10.1007/s00213-008-1273-x. View

16.

Fallahian F, Karami-Tehrani F, Salami S, Aghaei M . Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. FEBS J. 2011; 278(18):3360-9. DOI: 10.1111/j.1742-4658.2011.08260.x. View

17.

Hwang T, Leu Y, Kao S, Tang M, Chang H . Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway. Free Radic Biol Med. 2006; 41(9):1433-41. DOI: 10.1016/j.freeradbiomed.2006.08.001. View

18.

Tinsley H, Gary B, Keeton A, Lu W, Li Y, Piazza G . Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells. Cancer Prev Res (Phila). 2011; 4(8):1275-84. PMC: 3151326. DOI: 10.1158/1940-6207.CAPR-11-0095. View

19.

Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T . 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J Clin Invest. 2013; 123(2):787-99. PMC: 3561824. DOI: 10.1172/JCI64768. View

20.

Chen T, Wadsten P, Su S, Rawlinson N, Hofman F, Hill C . The type IV phosphodiesterase inhibitor rolipram induces expression of the cell cycle inhibitors p21(Cip1) and p27(Kip1), resulting in growth inhibition, increased differentiation, and subsequent apoptosis of malignant A-172 glioma cells. Cancer Biol Ther. 2002; 1(3):268-76. DOI: 10.4161/cbt.80. View